(US20160348091) Methods and systems for purifying cells and/or viruses are provided. The sample is added to a well disposed in a medium. A potential is applied across the medium to cause the contaminants to enter one or more walls of the well, and retain the cells and/or viruses in the well. The cells and/or viruses can be removed from the well, and optionally adhered or fixed to a surface, or detected. In one embodiment, the cells and/or viruses may be retained in the well by embedding in the medium. The medium including the embedded cells and/or viruses may be excised or otherwise removed and transferred to a glass slide or other solid surface.
DANNOUX THIERRY LUC ALAIN;HSIAO RAYMOND CHIH CHUNG;KLADIAS NIKOLAOS PANTELIS;RAI ROHIT;RIDGE JOHN RICHARD;SALTZER JR JOHN ROBERT;UKRAINCZYK LJERKA
(US20160355428) A glass sheet is formed on a mold into a glass article having a three-dimensional shape. The mold, with the glass article thereon, is arranged within an interior space of a radiation shield such that the mold is between a leading end barrier and a trailing end barrier of the radiation shield. The mold, glass article, and radiation shield are translated through a sequence of cooling stations while maintaining the mold between the leading and trailing end barriers, wherein the leading and trailing end barriers inhibit radiation heat transfer at leading and trailing ends of the mold.
(IN201637027582) The present invention relates to a pelleted acetylene black having a mass strength measured according to ASTM D 1937 10 of 200 N at most and an average pellet size measured according to ASTM D 1511 10 of at least 1.0 mm to the use of any of said pelleted acetylene blacks to produce a compound comprising a resin or polymer or rubber matrix and the acetylene black dispersed in said matrix and to a method for producing such a compound.
(US20160348116) Methods and compositions for reducing viral genome amounts in a target cell are provided. In the subject methods, the activity of a miRNA is inhibited in a manner sufficient to reduce the amount of viral genome in the target cell, e.g., by introducing a miRNA inhibitory agent in the target cell. Also provided are pharmaceutical compositions, kits and systems for use in practicing the subject methods. The subject invention finds use in a variety of applications, including the treatment of subjects suffering from a viral mediated disease condition, e.g., an HCV mediated disease condition.
(US20160347982) A composition for a heat cycle system comprising a working fluid for heat cycle containing trifluoroethylene, and a refrigerant oil (for example, an ester refrigerant oil, an ether refrigerant oil, a polyglycol refrigerant oil or a hydrocarbon refrigerant oil), and a heat cycle system employing the composition for a heat cycle system.